Splicing variant of hepcidin mRNA

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Hepcidin regulates iron metabolism by interacting with ferroportin.
• Abnormal iron accumulation is linked to cancer progression, including hepatoma.
• Hepcidin's role in iron metabolism makes it relevant to cancer development.

Purpose of the Study:

• To identify novel hepcidin transcripts in hepatoma.
• To investigate the presence and quantity of a variant hepcidin mRNA in cancer.
• To evaluate the potential of this variant as a biomarker for hepatocellular carcinoma (HCC).

Main Methods:

• Identification of a new alternative HAMP transcript in the HLF hepatoma cell line.
• Utilizing copy-based-digital PCR to quantify hepcidin mRNA variant copy numbers.
• Analyzing serum exosomes from HCC patients for the presence of the hepcidin mRNA variant.

Main Results:

• A novel alternative HAMP transcript lacking 60 internal bases was identified in hepatoma cells.
• Most hepatoma-derived cell lines showed significant copy numbers of this variant hepcidin mRNA.
• The copy number of the hepcidin mRNA variant was significantly elevated in serum exosomes of HCC patients.

Conclusions:

• A variant hepcidin mRNA transcript is present in hepatoma.
• Elevated levels of this variant in serum exosomes suggest its potential as a diagnostic marker.
• Quantification of exosomal hepcidin mRNA variant may offer a new avenue for HCC diagnosis.